90 related articles for article (PubMed ID: 17445401)
1. [Study on expression of mineralocorticoid receptor in human atria during atrial fibrillation].
Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):114-8. PubMed ID: 17445401
[TBL] [Abstract][Full Text] [Related]
2. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
[TBL] [Abstract][Full Text] [Related]
3. [Atrial 11beta-hydroxysteroid dehydrogenase type 2 expression in rheumatic heart disease patients with or without atrial fibrillation].
Pei DA; Li L; Xu ZY; Huang JY; Xu ZM; Wang M
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):385-9. PubMed ID: 19100026
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
[TBL] [Abstract][Full Text] [Related]
5. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
[TBL] [Abstract][Full Text] [Related]
6. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor, CYP11B2 mRNA expression, and atrial matrix remodelling in patients with atrial fibrillation.
Pei DA; Yan YY; Li L; Xu ZY; Huang JY; Wang M; Xu ZM; Yao Q; Huang SE; Huang Q; Wang SS
Acta Cardiol; 2010 Oct; 65(5):527-33. PubMed ID: 21125974
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
Tsai CT; Chiang FT; Tseng CD; Hwang JJ; Kuo KT; Wu CK; Yu CC; Wang YC; Lai LP; Lin JL
J Am Coll Cardiol; 2010 Feb; 55(8):758-70. PubMed ID: 20170814
[TBL] [Abstract][Full Text] [Related]
9. [The relation between angiotensin II receptors 1 and 2, and CYP11B2 and atrial structural remodeling in patients with atrial fibrillation].
Wu YQ; Wang XD; Fang H; Wang YL; Zhang YC; Su LJ
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2281-4. PubMed ID: 18001553
[TBL] [Abstract][Full Text] [Related]
10. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
Ke D; Xu CX; Lin YZ; Zhang JC; Chen L; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):459-63. PubMed ID: 15932710
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillation.
Uemura N; Ohkusa T; Hamano K; Nakagome M; Hori H; Shimizu M; Matsuzaki M; Mochizuki S; Minamisawa S; Ishikawa Y
Eur J Clin Invest; 2004 Nov; 34(11):723-30. PubMed ID: 15530144
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between atrial fibroblast proliferation/fibrosis and atrial fibrillation in patients with rheumatic heart disease].
Lin YZ; Cai JM; Chen L; Yang ZP; Zhang JC; Wu W; Ke D; Xu CX
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):813-7. PubMed ID: 20128380
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.
De-An P; Li L; Zhi-Yun X; Jin-Yu H; Zheng-Ming X; Min W; Qiang Y; Shi-Eng H
Clin Cardiol; 2010 Jan; 33(1):23-9. PubMed ID: 20063294
[TBL] [Abstract][Full Text] [Related]
14. [Alterations in gene expression of calcium handling proteins in patients with chronic atrial fibrillation].
Tang BP; Xu GJ; Shabiti Y; Yunus K; Abutirehemen M; Cheng ZH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):642-6. PubMed ID: 18051721
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of chronic atrial fibrillation combined with rheumatic mitral valve disease: Effects of the cryo-maze procedure and predictors for late recurrence.
Baek MJ; Na CY; Oh SS; Lee CH; Kim JH; Seo HJ; Park SW; Kim WS
Eur J Cardiothorac Surg; 2006 Nov; 30(5):728-36. PubMed ID: 17008109
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.
Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB
Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change.
Alessandri N; Tufano F; Petrassi M; Alessandri C; Di Cristofano C; Della Rocca C; Gallo P
Eur Rev Med Pharmacol Sci; 2009; 13(6):431-42. PubMed ID: 20085124
[TBL] [Abstract][Full Text] [Related]
18. [Expression of connexin in atrium of patients with atrial fibrillation and its signal transduction pathway].
Yan H; Chen JZ; Zhu JH; Ni YM; Yu GW; Hu SJ; Tao QM
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):209-13. PubMed ID: 15059536
[TBL] [Abstract][Full Text] [Related]
19. [Calpain-I, calpastatin, caspase-3 and apoptosis in the human left atrium in rheumatic atrial fibrillation].
Chen YQ; Wang L; Su X; Tao L; Chen XF
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):303-7. PubMed ID: 16776917
[TBL] [Abstract][Full Text] [Related]
20. Endocardial radiofrequency ablation during mitral valve surgery: effect on cardiac rhythm, atrial size, and function.
Fayad G; Le Tourneau T; Modine T; Azzaoui R; Ennezat PV; Decoene C; Deklunder G; Warembourg H
Ann Thorac Surg; 2005 May; 79(5):1505-11. PubMed ID: 15854924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
